Literature DB >> 9492844

Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice.

Z An1, X Wang, J Geller, A R Moossa, R M Hoffman.   

Abstract

BACKGROUND: Prostate cancer is the second leading cause of male death in the United States. When diagnosed, nearly half the cases have metastatic lesions. An animal model of human prostate cancer demonstrating spontaneous metastasis from the orthotopic site after tumor implantation should be of great help for us to understand the disease and to formulate treatment strategy. We report here a high metastatic model of human prostate cancer PC-3.
METHODS: We developed microsurgical techniques, termed surgical orthotopic implantation (SOI), to implant histologically intact tumor tissues orthotopically in immunodeficient mice. In this study intact tissue of the human prostate cancer cell line PC-3, harvested from a subcutaneous tumor in a nude mouse, was implanted to the ventral lateral lobes of the prostate gland in a series of nude mice. Mice were sacrificed when found moribund, and autopsy and histology were performed subsequently.
RESULTS: A high frequency of lymph node and lung metastasis was noted upon histological examination. The extensive and widespread lung metastasis following orthotopic implantation of PC-3 is, to the best of our knowledge, the first report in the literature.
CONCLUSIONS: In contrast to orthotopic injection of cell suspensions, no multiple metastatic cell selection was necessary after SOI for significant expression of the metastatic potential of PC-3. We conclude that the stromal tissue architecture maintained in the implanted tumor played a critical role in tumor growth and progression.

Entities:  

Mesh:

Year:  1998        PMID: 9492844     DOI: 10.1002/(sici)1097-0045(19980215)34:3<169::aid-pros3>3.0.co;2-d

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  18 in total

1.  [89Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model.

Authors:  Kirstin A Zettlitz; Wen-Ting K Tsai; Scott M Knowles; Felix B Salazar; Naoko Kobayashi; Robert E Reiter; Anna M Wu
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

2.  Structure and Function of a Prostate Cancer Dissemination-Permissive Extracellular Matrix.

Authors:  Marie-France Penet; Samata Kakkad; Arvind P Pathak; Balaji Krishnamachary; Yelena Mironchik; Venu Raman; Meiyappan Solaiyappan; Zaver M Bhujwalla
Journal:  Clin Cancer Res       Date:  2016-10-31       Impact factor: 12.531

3.  In vitro and in vivo model systems used in prostate cancer research.

Authors:  David Cunningham; Zongbing You
Journal:  J Biol Methods       Date:  2015

4.  Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection.

Authors:  Z An; P Jiang; X Wang; A R Moossa; R M Hoffman
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

Review 5.  Drug discovery in prostate cancer mouse models.

Authors:  Kenneth C Valkenburg; Kenneth J Pienta
Journal:  Expert Opin Drug Discov       Date:  2015-06-01       Impact factor: 6.098

6.  Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

Authors:  Z M Bhujwalla; D Artemov; K Natarajan; E Ackerstaff; M Solaiyappan
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

7.  [From tumor tissue via primary cultures to xenograft models: a functional approach in prostate cancer research].

Authors:  M Saar; J Kamradt; V Jung; M Stöckle; G Unteregger
Journal:  Urologe A       Date:  2011-08       Impact factor: 0.639

8.  Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft.

Authors:  Marie-France Penet; Arvind P Pathak; Venu Raman; Paloma Ballesteros; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2009-10-27       Impact factor: 12.701

9.  Pre-clinical Orthotopic Murine Model of Human Prostate Cancer.

Authors:  Varahram Shahryari; Hannah Nip; Sharanjot Saini; Altaf A Dar; Soichiro Yamamura; Yozo Mitsui; Melissa Colden; Nathan Bucay; Laura Z Tabatabai; Kirsten Greene; Guoren Deng; Yuichiro Tanaka; Rajvir Dahiya; Shahana Majid
Journal:  J Vis Exp       Date:  2016-08-29       Impact factor: 1.355

10.  Protein 4.1B suppresses prostate cancer progression and metastasis.

Authors:  Sunny Y Wong; Herbert Haack; Joseph L Kissil; Marc Barry; Roderick T Bronson; Steven S Shen; Charles A Whittaker; Denise Crowley; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.